268
Views
39
CrossRef citations to date
0
Altmetric
Research Article

Application of Pharmacogenomics in Clinical Pharmacology

, PhD, FCP, , , &
Pages 89-99 | Received 18 Sep 2005, Accepted 09 Nov 2005, Published online: 09 Oct 2008

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Gary E. Swan & Christina N. Lessov-Schlaggar. (2009) Tobacco Addiction and Pharmacogenetics of Nicotine Metabolism. Journal of Neurogenetics 23:3, pages 262-271.
Read now

Articles from other publishers (38)

Médéric Mouterde, Youssef Daali, Victoria Rollason, Martina Čížková, Anwar Mulugeta, Khalid A Al Balushi, Giannoulis Fakis, Theodoros C Constantinidis, Khalid Al-Thihli, Marie Černá, Eyasu Makonnen, Sotiria Boukouvala, Said Al-Yahyaee, Getnet Yimer, Viktor Černý, Jules Desmeules & Estella S Poloni. (2022) Joint Analysis of Phenotypic and Genomic Diversity Sheds Light on the Evolution of Xenobiotic Metabolism in Humans. Genome Biology and Evolution 14:12.
Crossref
Mahadevabharath R. Somayaji, Debarun Das, Harsha Teja Garimella, Carrie L. German, Andrzej J. Przekwas & Laurent Simon. (2021) An integrated biophysical model for predicting the clinical pharmacokinetics of transdermally delivered compounds. European Journal of Pharmaceutical Sciences 167, pages 105924.
Crossref
Maaike van der Lee, Marjolein Kriek, Henk-Jan Guchelaar & Jesse J. Swen. (2020) Technologies for Pharmacogenomics: A Review. Genes 11:12, pages 1456.
Crossref
Lena King, Mallé Jurima‐Romet & Nita Ichhpurani. 2020. Biomarkers in Drug Discovery and Development. Biomarkers in Drug Discovery and Development 485 504 .
Rui Xue, Jie Liao, Xin Shao, Ke Han, Jingbo Long, Li Shao, Ni Ai & Xiaohui Fan. (2019) Prediction of Adverse Drug Reactions by Combining Biomedical Tripartite Network and Graph Representation Model. Chemical Research in Toxicology 33:1, pages 202-210.
Crossref
Xiaoqiang Xiang & Yawen Yuan. 2020. Pharmacogenomics in Precision Medicine. Pharmacogenomics in Precision Medicine 257 276 .
Kaiser Jamil, Vidya Kandula, Ramoji Kandula, M. Asimuddin, Sindu Joshi & Shiva Kumar Yerra. (2014) Polymorphism of CYP3A4*2 and eNOS genes in the diabetic patients with hyperlipidemia undergoing statin treatment. Molecular Biology Reports 41:10, pages 6719-6727.
Crossref
Liangfu Chen & Joseph W. Polli. 2013. Pharmacogenomics of Human Drug Transporters. Pharmacogenomics of Human Drug Transporters 13 37 .
Raymond L. Woosley. (2013) One Hundred Years of Drug Regulation: Where Do We Go from Here?. Annual Review of Pharmacology and Toxicology 53:1, pages 255-273.
Crossref
Larisa H. Cavallari, Teri E. Klein & Shiew-Mei Huang. 2013. Pharmacogenomics. Pharmacogenomics 63 88 .
Shyh-Yuh Liou, Fran Stringer & Masashi Hirayama. (2012) The Impact of Pharmacogenomics Research on Drug Development. Drug Metabolism and Pharmacokinetics 27:1, pages 2-8.
Crossref
Michael S. Roberts. (2010) Drug structure–transport relationships. Journal of Pharmacokinetics and Pharmacodynamics 37:6, pages 541-573.
Crossref
Carl C. Peck. (2010) Quantitative clinical pharmacology is transforming drug regulation. Journal of Pharmacokinetics and Pharmacodynamics 37:6, pages 617-628.
Crossref
Pamela J. White. (2010) Patient Factors That Influence Warfarin Dose Response. Journal of Pharmacy Practice 23:3, pages 194-204.
Crossref
Shayne Cox GadLena King, Mallé Jurima-Romet & Nita Ichhpurani. 2010. Pharmaceutical Sciences Encyclopedia. Pharmaceutical Sciences Encyclopedia.
Shayne Cox GadMichael R. Bleavins, Claudio Carini, Malle Jurima-Romet & Ramin Rahbari. 2010. Pharmaceutical Sciences Encyclopedia. Pharmaceutical Sciences Encyclopedia.
Lorrie Dawson & Shelanne Lighthouse. (2010) Assessment of Self-Efficacy for Cultural Competence in Prescribing. The Journal for Nurse Practitioners 6:1, pages 44-48.
Crossref
Bryan Ballantyne, Timothy C. Marrs & Tore Syversen. 2009. General, Applied and Systems Toxicology. General, Applied and Systems Toxicology.
Akihiro Hisaka, Makiko Kusama, Yoshiyuki Ohno, Yuichi Sugiyama & Hiroshi Suzuki. (2009) A Proposal for a Pharmacokinetic Interaction Significance Classification System (PISCS) Based on Predicted Drug Exposure Changes and Its Potential Application to Alert Classifications in Product Labelling. Clinical Pharmacokinetics 48:10, pages 653-666.
Crossref
Melissa D. Johnson. (2009) Pharmacogenomics of systemic antifungal agents. Current Fungal Infection Reports 3:2, pages 111-116.
Crossref
Masahiko Nishiyama & Hidetaka Eguchi. (2009) Recent Advances in Cancer Chemotherapy: Current Strategies, Pharmacokinetics, and Pharmacogenomics. Advanced Drug Delivery Reviews 61:5, pages 367-368.
Crossref
Masahiko Nishiyama & Hidetaka Eguchi. (2009) Pharmacokinetics and pharmacogenomics in gastric cancer chemotherapy. Advanced Drug Delivery Reviews 61:5, pages 402-407.
Crossref
Alison Vickers. 2008. Genomics. Genomics 175 189 .
Shiew-Mei Huang, Myong-Jin Kim, Federico Goodsaid, Felix Frueh & Lawrence Lesko. 2008. Genomics. Genomics 357 378 .
Shiew-Mei Huang, John M. Strong, Lei Zhang, Kellie S. Reynolds, Srikanth Nallani, Robert Temple, Sophia Abraham, Sayed Al Habet, Raman K. Baweja, Gilbert J. Burckart, Sang Chung, Philip Colangelo, David Frucht, Martin D. Green, Paul Hepp, Elena Karnaukhova, Hon-Sum Ko, Jang-Ik Lee, Patrick J. Marroum, Janet M. Norden, Wei Qiu, Atiqur Rahman, Solomon Sobel, Toni Stifano, Kenneth Thummel, Xiao-Xiong Wei, Sally Yasuda, Jenny H. Zheng, Hong Zhao & Lawrence J. Lesko. (2008) New Era in Drug Interaction Evaluation: US Food and Drug Administration Update on CYP Enzymes, Transporters, and the Guidance Process. The Journal of Clinical Pharmacology 48:6, pages 662-670.
Crossref
Scott Sasjack. (2021) Demanding Individually Safe Drugs Today: Overcoming the Cross-Labeling Legal Hurdle to Pharmacogenomics. American Journal of Law & Medicine 34:1, pages 7-40.
Crossref
Janet WoodcockRaymond Woosley. (2008) The FDA Critical Path Initiative and Its Influence on New Drug Development. Annual Review of Medicine 59:1, pages 1-12.
Crossref
Kenichi IMAGAWA, Tsugutaka ITO & Junichi AZUMA. (2008) . Rinsho yakuri/Japanese Journal of Clinical Pharmacology and Therapeutics 39:2, pages 61-67.
Crossref
Myong-Jin Kim, Shiew-Mei Huang, Atiqur Rahman, Felix W. Frueh & Lawrence J. Lesko. 2008. Pharmacogenomics and Personalized Medicine. Pharmacogenomics and Personalized Medicine 55 71 .
Jochen Schmitt. 2008. Encyclopedia of Public Health. Encyclopedia of Public Health 1176 1186 .
Marjorie Romkes. 2008. Encyclopedia of Public Health. Encyclopedia of Public Health 1101 1104 .
Donglu Zhang, Duxi Zhang, Dan Cui, Janice Gambardella, Li Ma, Anthony Barros, Lifei Wang, Yunlin Fu, Sandhya Rahematpura, Julia Nielsen, Michael Donegan, Hongjian Zhang & W. Griffith Humphreys. (2007) Characterization of the UDP Glucuronosyltransferase Activity of Human Liver Microsomes Genotyped for the UGT1A1*28 Polymorphism . Drug Metabolism and Disposition 35:12, pages 2270-2280.
Crossref
Naoko Matsumoto, Fumiko Kakihara, Sayaka Kimura, Yukari Kurebayashi, Mitsuharu Hirai, Masafumi Yohda & Setsuo Hasegawa. (2007) Single nucleotide polymorphism genotyping of CYP2C19 using a new automated system. Analytical Biochemistry 370:1, pages 121-123.
Crossref
Kathleen M. Giacomini, Ronald M. Krauss, Dan M. Roden, Michel Eichelbaum, Michael R. Hayden & Yusuke Nakamura. (2007) When good drugs go bad. Nature 446:7139, pages 975-977.
Crossref
Danial E. Baker. (2017) Pharmacogenetics and Warfarin Dosing: Has the Time Come for Routine Application?. Hospital Pharmacy 42:1, pages 9-10.
Crossref
G. Suman .Kaiser Jamil .. (2006) Novel CYP3A4 Gene Polymorphisms in Post Chemo Breast Cancer Patients. International Journal of Cancer Research 2:4, pages 358-366.
Crossref
Hany H. Ezzeldin & Robert B. Diasio. (2006) Genetic Testing in Cancer Therapeutics. Clinical Cancer Research 12:14, pages 4137-4141.
Crossref
Ruth March. (2006) Challenges and opportunities of pharmacogenetics in drug development. Personalized Medicine 3:2, pages 195-206.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.